Literature DB >> 6202538

Malignant mesothelioma of the pleura: clinical aspects and symptomatic treatment.

M R Law, M E Hodson, M Turner-Warwick.   

Abstract

A series of 140 patients with malignant pleural mesothelioma is reported. Clinical presentation was delayed in cases without a large effusion, but there was extensive tumour at presentation, shown by thoracoscopy, thoracotomy or computed tomography, in all patients investigated. Thoracoscopy was a useful diagnostic alternative to thoracotomy. With progression of disease, mesothelial extension was more important than distant metastases, which were usually too small and sparse to produce symptoms. Skin deposits of tumour in sites of previous invasive procedures did not cause pain or other clinical problems, and we consider that diagnostic and therapeutic procedures should not be withheld to avoid them. In the management of recurrent pleural effusions, intrapleural bleomycin, preceded by aspiration and followed by suction, was a useful alternative to surgery. Pneumothorax, spontaneous or iatrogenic, required decortication. Adequate pain relief was difficult; radiotherapy and nerve blocking procedures were not effective and opiates were often necessary.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6202538

Source DB:  PubMed          Journal:  Eur J Respir Dis        ISSN: 0106-4339


  11 in total

Review 1.  Biopsies in patients with intrathoracic disease.

Authors:  G A Lillington; W SooHoo
Journal:  Clin Rev Allergy       Date:  1990 Summer-Fall

2.  Survival and relapse pattern after trimodality therapy for malignant pleural mesothelioma.

Authors:  Kenichi Okubo; Makoto Sonobe; Takuji Fujinaga; Tsuyoshi Shoji; Hiroaki Sakai; Ryo Miyahara; Toru Bando; Hiroshi Date; Keiko Shibuya; Masahiro Hiraoka
Journal:  Gen Thorac Cardiovasc Surg       Date:  2009-11-12

Review 3.  Malignant mesothelioma: new insights into tumour biology and immunology as a basis for new treatment approaches.

Authors:  J W Upham; M J Garlepp; A W Musk; B W Robinson
Journal:  Thorax       Date:  1995-08       Impact factor: 9.139

4.  Targeting mesothelioma using an infectivity enhanced survivin-conditionally replicative adenoviruses.

Authors:  Zeng B Zhu; Sharmila K Makhija; Baogen Lu; Minghui Wang; Shuyi Wang; Koichi Takayama; Gene P Siegal; Paul N Reynolds; David T Curiel
Journal:  J Thorac Oncol       Date:  2006-09       Impact factor: 15.609

5.  [Pleural mesothelioma--problems in diagnosis and clinical course in 25 patients].

Authors:  F Liewald; L Sunder-Plassmann; H Dienemann; J Mezger
Journal:  Langenbecks Arch Chir       Date:  1989

6.  Extrapleural pneumonectomy in the multimodality therapy of malignant pleural mesothelioma. Results in 120 consecutive patients.

Authors:  D J Sugarbaker; J P Garcia; W G Richards; D H Harpole; E Healy-Baldini; M M DeCamp; S J Mentzer; M J Liptay; G M Strauss; S J Swanson
Journal:  Ann Surg       Date:  1996-09       Impact factor: 12.969

Review 7.  Cerebral metastases in pleural mesothelioma: case report and review of the literature.

Authors:  M Wroński; M Burt
Journal:  J Neurooncol       Date:  1993-07       Impact factor: 4.130

8.  A case of pleural mesothelioma with effusive-constrictive pericarditis.

Authors:  N A Weir; B Gerstenhaber
Journal:  Yale J Biol Med       Date:  2001 May-Jun

9.  Pleural mesothelioma presenting as periumbilical metastasis: the first clinical documentation.

Authors:  R F Falkenstern-Ge; M Kimmich; S Bode-Erdmann; G Friedel; G Ott; M Kohlhäufl
Journal:  Case Rep Oncol Med       Date:  2013-04-18

10.  Protocol for PIT: a phase III trial of prophylactic irradiation of tracts in patients with malignant pleural mesothelioma following invasive chest wall intervention.

Authors:  N Bayman; D Ardron; L Ashcroft; D R Baldwin; R Booton; L Darlison; J G Edwards; L Lang-Lazdunski; J F Lester; M Peake; R C Rintoul; M Snee; P Taylor; C Lunt; C Faivre-Finn
Journal:  BMJ Open       Date:  2016-01-27       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.